Evidence map›Paper›PMID 42525131›Full record

ArticleActa diabetologica2026

Migration background and diabetes technology use at diagnosis and follow-up in children and adolescents with type 1 diabetes: a single-centre study.

Dagmar Meraner, Marjan Arvandi, Katharina Pajk, Eva Vonmetz, Wilhelm Oberaigner, Veronika Haslwanter, Sibylle Puntscher, Elisabeth Binder, Elisabeth Steichen, Uwe Siebert and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Acta diabetologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Dagmar MeranerDepartment of Pediatrics 1, Medical University of Innsbruck, Innsbruck, 6020, Austria.
Marjan ArvandiInstitute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT TIROL - University for Health Sciences and Technology, Eduard-Wallnoefer-Zentrum 1, Hall in Tirol, 6060, Austria.
Katharina PajkDepartment of Pediatrics 1, Medical University of Innsbruck, Innsbruck, 6020, Austria.
Eva VonmetzDepartment of Pediatrics 1, Medical University of Innsbruck, Innsbruck, 6020, Austria.
Wilhelm OberaignerInstitute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT TIROL - University for Health Sciences and Technology, Eduard-Wallnoefer-Zentrum 1, Hall in Tirol, 6060, Austria.
Veronika HaslwanterInstitute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT TIROL - University for Health Sciences and Technology, Eduard-Wallnoefer-Zentrum 1, Hall in Tirol, 6060, Austria.
Sibylle PuntscherInstitute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT TIROL - University for Health Sciences and Technology, Eduard-Wallnoefer-Zentrum 1, Hall in Tirol, 6060, Austria.
Elisabeth BinderDepartment of Pediatrics 1, Medical University of Innsbruck, Innsbruck, 6020, Austria.
Elisabeth SteichenDepartment of Pediatrics 1, Medical University of Innsbruck, Innsbruck, 6020, Austria.
Uwe SiebertInstitute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT TIROL - University for Health Sciences and Technology, Eduard-Wallnoefer-Zentrum 1, Hall in Tirol, 6060, Austria.
Ines SchafferDepartment of Pediatrics 1, Medical University of Innsbruck, Innsbruck, 6020, Austria.
Sabine E HoferDepartment of Pediatrics 1, Medical University of Innsbruck, Innsbruck, 6020, Austria. sabine.e.hofer@i-med.ac.at.ORCID http://orcid.org/0000-0001-6778-0062
Daniela SchmidFaculty of Life Sciences, Albstadt-Sigmaringen University, Sigmaringen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo investigate whether migration background is associated with diabetes technology use at diagnosis and during follow-up in children and adolescents with type 1 diabetes.

methodsThis cross-sectional study included children and adolescents aged 4-19 years with type 1 diabetes duration ≥ 1 year. Insulin pump therapy at diagnosis and diabetes technology use at follow-up (defined as insulin pump therapy or automated insulin delivery [AID]) were compared between participants with and without migration background. Multivariable logistic regression was used to assess factors associated with technology use.

resultsA total of 143 participants (mean age 13.2 ± 3.7 years) were included, of whom 24.5% had a migration background. At diabetes onset, insulin pump therapy was less frequent in participants with migration background compared to those without (28.6% vs. 50.0%, p = 0.027). At follow-up, diabetes technology use was numerically lower in participants with migration background (60.0% vs. 76.8%); however, the difference did not reach statistical significance (p = 0.052). In adjusted analyses, migration background was not significantly associated with diabetes technology use at follow-up (OR 2.33, 95% CI 0.92-5.89), whereas younger age and longer diabetes duration were independently associated with technology use.

conclusionsChildren with migration background were less likely to receive insulin pump therapy at diagnosis. At follow-up, differences in diabetes technology use were smaller and not statistically significant. These findings are consistent with the hypothesis of delayed technology uptake, although longitudinal studies are required to determine the timing of diabetes technology initiation.

Indexed as

Automated insulin deliveryInsulin pumpMigration backgroundPediatric diabetesType 1 diabetes

Identifiers

PMID42525131

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.